Project Grant HT9425261E324
Award Date 9/30/26
Completion Date 9/29/28
Dollars Obligated $525K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37232, USA
Similar Awards
- Federal Grant Award Summary Vanderbilt University Medical Center received a $1,847,457 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2030. The grant supports "Building on the Foundation of the Academy of Kidney Cancer Investigators," a research initiative aimed at advancing biomedical research to transform healthcare for service members and the American public...
- Federal Project Grant Award Summary Vanderbilt University Medical Center (VUMC) received a $700,000 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on August 15, 2025, with a completion date of August 14, 2027. The award supports research investigating the DPEP1-neutrophil axis in microsatellite stable colorectal cancer, contributing to the DHA's broader mission of transforming healthcare for service members and the...
- Federal Project Grant Award Summary Vanderbilt University Medical Center received a $560,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the project titled "Fundamental Mechanisms of Wnt-Driven Metastasis." The award, issued July 1, 2026, with a completion date of June 30, 2028, supports basic biomedical research investigating the molecular mechanisms by which Wnt signaling drives metastatic cancer...
- Federal Grant Award Summary Vanderbilt University Medical Center (VUMC) received a $2.39 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025, through July 31, 2029. The award funds biomedical research investigating the molecular basis of post-injury syndrome and mineralization disorders, with particular focus on decoding inflammatory mechanisms underlying these conditions. This research...
- The U.S. Department of Defense's Defense Health Agency awarded a $1,317,028 Project Grant to Vanderbilt University Medical Center (VUMC) with a period of performance from June 1, 2024 to May 31, 2028. The grant, under CFDA 12.420 - Military Medical Research and Development program, will support VUMC's research into therapeutic interventions to reverse gastric precancer. As a leading academic medical center and biomedical research institution, VUMC will leverage its clinical expertise and...
- Federal Project Grant Award Summary Vanderbilt University Medical Center (VUMC) received a $1.17 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct research on optimizing lung cancer screening guidelines for all Americans. The award, obligated on July 31, 2026, supports a three-year research initiative extending through July 30, 2029, and will be performed at VUMC's Nashville, Tennessee location....
- This federal Project Grant award of $1,136,506.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research by Vanderbilt University Medical Center (VUMC) on INTEGRIN BETA1, a mediator of clear cell renal cell carcinoma metastasis and growth. The award commenced on Sep 1, 2024 and is scheduled for completion by Aug 31, 2028. VUMC, a prominent academic medical center and nonprofit healthcare provider, will conduct this specialized...
- This $1,211,469 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a therapeutic intervention research project to reverse gastric precancer conducted by Vanderbilt University Medical Center (VUMC). The award, with a performance period from June 1, 2024 to May 31, 2028, will enable VUMC to leverage its clinical expertise and research capabilities to advance medical knowledge and improve patient care. As a leading...
- This federal Project Grant award in the amount of $962,697.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research by Vanderbilt University Medical Center (VUMC) on integrin beta1, a mediator of clear cell renal cell carcinoma metastasis and growth. The research aims to advance the understanding and treatment of this form of kidney cancer, with potential applications for improving healthcare outcomes...
- Federal Project Grant Award Summary Vanderbilt University Medical Center received a $1,267,303 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct a three-year research initiative titled "Defining Chronic Immune-Related Adverse Events in Melanoma Survivors." The award, effective August 1, 2025, through July 31, 2028, supports hypothesis-driven biomedical research focused on understanding and...